Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (50.0%)Phase 4
1 (50.0%)Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 226
- Registration Number
- NCT02332954
- Locations
- 🇨🇦
CA004, Edmonton, Alberta, Canada
🇨🇦CA005, Kelowna, British Columbia, Canada
🇨🇦CA006, St. John's, Newfoundland and Labrador, Canada
Real Life Assessment of Abilify Maintena
Terminated
- Conditions
- Schizophrenia
- First Posted Date
- 2014-05-06
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT02131415
- Locations
- 🇨🇦
CA012, Calgary, Alberta, Canada
🇨🇦CA008, Penticton, British Columbia, Canada
🇨🇦CA017, Vancouver, British Columbia, Canada
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
Phase 3
Completed
- Conditions
- Indolent Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01500083
- Locations
- 🇨🇦
CA015, Calgary, Alberta, Canada
🇨🇦CA014, Edmonton, Alberta, Canada
🇨🇦CA016, Kelowna, British Columbia, Canada
News
No news found